|Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo …|
F Olldashi, M Kerçi, T Zhurda, K Ruçi, A Banushi, MS Traverso, J Jiménez, ...
The Lancet 376 (9734), 23-32, 2010
|Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial|
CRASH Trial Collaborators
The Lancet 364 (9442), 1321-1328, 2004
|Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients|
MRC Crash Trial Collaborators
Bmj 336 (7641), 425-429, 2008
|Treatment for primary postpartum haemorrhage|
HA Mousa, J Blum, G Abou El Senoun, H Shakur, Z Alfirevic
Cochrane database of systematic reviews, 2014
|Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months|
CRASH Trial Collaborators
The Lancet 365 (9475), 1957-1959, 2005
|Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis|
K Ker, P Edwards, P Perel, H Shakur, I Roberts
Bmj 344, 2012
|Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised …|
H Shakur, I Roberts, B Fawole, R Chaudhri, M El-Sheikh, A Akintan, ...
The Lancet 389 (10084), 2105-2116, 2017
|The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in …|
I Roberts, H Shakur, T Coats, B Hunt, E Balogun, L Barnetson, L Cook, ...
Health Technology Assessment (Winchester, England) 17 (10), 1, 2013
|The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo …|
H Shakur, D Elbourne, M Gülmezoglu, Z Alfirevic, C Ronsmans, E Allen, ...
Trials 11 (1), 1-14, 2010
|GBD 2010: understanding disease, injury, and risk.|
Lancet (London, England) 380 (9859), 2053-2054, 2012
|Patient outcome after traumatic brain injury in high-, middle-and low-income countries: analysis of data on 8927 patients in 46 countries|
MJ De Silva, I Roberts, P Perel, P Edwards, MG Kenward, J Fernandes, ...
International journal of epidemiology 38 (2), 452-458, 2009
|CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a …|
H Shakur, I Roberts, R Bautista, J Caballero, T Coats, Y Dewan, ...
Lancet 376 (9734), 23-32, 2010
|Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial|
C Guerriero, J Cairns, P Perel, H Shakur, I Roberts, ...
PLoS One 6 (5), e18987, 2011
|Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 …|
A Gayet-Ageron, D Prieto-Merino, K Ker, H Shakur, FX Ageron, I Roberts, ...
The Lancet 391 (10116), 125-132, 2018
|Antifibrinolytic drugs for acute traumatic injury|
I Roberts, H Shakur, K Ker, T Coats
Cochrane Database of Systematic Reviews, 2012
|CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial|
Y Dewan, EO Komolafe, JH Mejía-Mantilla, P Perel, I Roberts, H Shakur
Trials 13 (1), 1-14, 2012
|Anti-fibrinolytic agents in post partum haemorrhage: a systematic review|
P Ferrer, I Roberts, E Sydenham, K Blackhall, H Shakur
BMC pregnancy and childbirth 9 (1), 1-6, 2009
|Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review|
TD Ngo, MH Park, H Shakur, C Free
Bulletin of the World Health Organization 89, 360-370, 2011
|Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial|
I Roberts, P Perel, D Prieto-Merino, H Shakur, T Coats, BJ Hunt, F Lecky, ...
Bmj 345, 2012
|European society of intensive care medicine study of therapeutic hypothermia (32-35 C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial)|
PJD Andrews, HL Sinclair, CG Battison, KH Polderman, G Citerio, ...
Trials 12 (1), 1-13, 2011